I am a trusted advisor and partner to entrepreneurs and investors in capital markets and mergers and acquisitions transactions.

Experience

Breton Technology Announces HK$234 Million IPO

May 7, 2025

Cooley advised Breton Technology, an electric-powered engineering machinery provider based in China, on its HK$234 million global initial public offering (IPO).

Read more

Related contacts

Ethan Jin
Partner, Beijing
Will Cai
Partner, Hong Kong
Caroline Hobson
Partner, London
Lisa Yuan
Special Counsel, Beijing
Karen Tsai
Special Counsel, Washington, DC
Marcus Chen
Associate, Beijing
Dichun Duan
Associate, Beijing
Juan Nascimbene
Associate, London
Chad Li
International Legal Project Manager, Beijing
Zoe Wang
International Legal Project Manager, Shanghai
Jin Wang
Senior Legal Assistant, Beijing

Related Practices & Industries

VISEN Pharmaceuticals Announces HK$783 Million IPO

March 21, 2025

Cooley advised VISEN Pharmaceuticals, a late-stage, near-commercialization biopharmaceutical company focused on providing treatments for select endocrine diseases in Greater China (including Hong Kong, Macau and Taiwan), on its HK$783 million (approximately US$101 million) initial public offering (IPO) on the Stock Exchange of Hong Kong, subject to the exercise of a 15% overallotment option.

Read more

Related contacts

Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Will Cai
Partner, Hong Kong
Annie Froehlich
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Aaron Pomeroy
Partner, Colorado
Francis Wheeler
Senior Counsel, Colorado
Hilda Li
Associate, Hong Kong
Ying Liu
Associate, Hong Kong
Amanda Pacheco
Associate, Palo Alto
Hardy Zhou
Associate, New York
Alex Wu
Associate, Shanghai
Philip Kwan
Senior Legal Assistant, Hong Kong
Kaiting Yang
Associate, Hong Kong

Related Practices & Industries

Bitdeer Announces $400 Million Convertible Senior Notes Offering

November 26, 2024

Cooley advised Bitdeer Technologies Group (Nasdaq: BTDR), a world-leading technology company for blockchain and high-performance computing, on its $360 million principal amount of 5.25% convertible senior notes due 2029, which includes the option for initial purchasers to purchase up to an additional $40 million principal amount of notes.

Read more

Related contacts

Will Cai
Partner, Hong Kong
Jason Savich
Partner, San Francisco
Mischi a Marca
Partner, San Francisco
Hilda Li
Associate, Hong Kong
Timothy Nguyen
Special Counsel, San Francisco

Related Practices & Industries

Gracell Biotechnologies Agrees to Acquisition by AstraZeneca for up to $1.2 Billion

December 26, 2023

Cooley advised Gracell Biotechnologies, a global clinical-stage biopharmaceutical company dedicated to developing innovative cell therapies for the treatment of cancer and autoimmune diseases, on its definitive agreement to be acquired by AstraZeneca.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Rowook Park
Partner, San Diego
Izzy Lubarsky
Partner, New York
Brittany K. Wightman
Associate, San Diego
Rajdeep Roger Bains
Associate, San Diego
Will Cai
Partner, Hong Kong
Patrick Loofbourrow
Partner, Singapore
Jie Zhang
Counsel, Hong Kong
Hilda Li
Associate, Hong Kong
Alessandra Murata
Partner, Palo Alto
Charity Williams
Partner, San Diego
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Megan Browdie
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Natasha Leskovsek
Of Counsel, Washington, DC
Rena Kaminsky
Special Counsel, Palo Alto
Stella Sarma
Partner, Brussels
Christine Graham
Special Counsel, London
Andrew Epstein
Special Counsel, Seattle
Dillon Martinson
Special Counsel, Washington, DC
Sara Kim
Associate, Los Angeles
Patrick Sharma
Associate, Santa Monica
Allison Kutner
Associate, New York
Eileen Leman
Associate, Los Angeles
Sarah Oliai
Associate, Washington, DC

Related Practices & Industries

Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by Syndicate of Premier Healthcare Investors

August 9, 2023

Cooley advised Gracell Biotechnologies, a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment of cancer and autoimmune diseases, on its private placement financing of up to $150 million.

Read more

Related contacts

Will Cai
Partner, Hong Kong
Jie Zhang
Counsel, Hong Kong
Francis Wheeler
Senior Counsel, Colorado
Hilda Li
Associate, Hong Kong
Harvey Yao
Associate, Hong Kong
Zhengyang Li
International Legal Project Manager, Hong Kong

Related Practices & Industries

View more

Admissions and credentials

California

Solicitor of Hong Kong